Peter B. Schiff

NYU Langone Health — United States

Physics and Astronomy · Physical Sciences

36h-index11.2kcitations212works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Radiotherapy Techniques(45), Prostate Cancer Diagnosis and Treatment(35), Endometrial and Cervical Cancer Treatments(34), Prostate Cancer Treatment and Research(21), Cancer Treatment and Pharmacology(16)

Publications211 total

Factors associated with treatment delay for cervical cancer patients treated with definitive chemoradiation and brachytherapy
International Journal of Gynecological Cancer·2025
Rates of Fertility/Hormonal Preservation among Locally Advanced Cervical Cancer Patients Treated with Definitive Chemoradiation and Brachytherapy
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
Toxicity Outcomes in Bladder Cancer Treated with Tri-Modality Therapy Using Hypofractionated Bladder Only Radiation with or without Immunotherapy
International Journal of Radiation Oncology*Biology*Physics·2025
Identification of Key Anatomic Structures on Magnetic Resonance Imaging During Prostate Stereotactic Body Radiation Therapy for Dose Avoidance to Reduce Erectile Dysfunction Risk
Practical Radiation Oncology·2025· 1 cited
Organ preservation in muscle-invasive urothelial bladder cancer
Current Opinion in Oncology·2024· 1 cited
Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIUC): A multicenter phase 2 trial.
Journal of Clinical Oncology·2023· 8 cited
Supplementary Data from Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
2023Open Access
Supplementary Data from Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
2023Open Access
Data from Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
2023Open Access
Data from Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
2023Open Access
Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study
Radiotherapy and Oncology·2023· 13 citedOpen Access
PO40  Presentation Time: 4:45 PM
Brachytherapy·2022Open Access
Stereotactic Body Radiation Therapy for the Treatment of Locally Recurrent and Oligoprogressive Non-Small Cell Lung Cancer: A Single Institution Experience
Frontiers in Oncology·2022· 2 citedOpen Access
Development of a Big Data Radiation Oncology Dashboard
International Journal of Radiation Oncology*Biology*Physics·2021· 2 citedOpen Access
A Sexual and Gender Minority Inclusive Tool to Identify and Reduce Psychological Distress Related to Vaginal Brachytherapy Treatment
International Journal of Radiation Oncology*Biology*Physics·2021· 2 cited
Retrospective Cohort Study of Oligometastatic and Oligoprogressive Malignancy Treated With Stereotactic Body Radiation Therapy (SBRT) With Intent to Delay New Systemic Therapy
International Journal of Radiation Oncology*Biology*Physics·2021Open Access
Treating through the surge: institutional experience of definitive management of cervical cancer patients at an urban institution during the COVID-19 pandemic
Gynecologic Oncology·2021Open Access
Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.
Journal of Clinical Oncology·2021· 42 cited
Intraoperative Ultrasound Guided Intracavitary Brachytherapy: Improving Toxicity and Precision of Tandem Applicator Placement in Cervical Cancer
International Journal of Radiation Oncology*Biology*Physics·2020Open Access
Modern Management of High-risk Soft Tissue Sarcoma With Neoadjuvant Chemoradiation
American Journal of Clinical Oncology·2020· 4 cited
page 1 of 11Next →

Frequent Co-authors

Ronald D. Ennis(10), Jason D. Wright(7), William M. Burke(7), Thomas J. Herzog(7), Susan Band Horwitz(5), Carmel J. Cohen(5), Mitchell C. Benson(5), Eric J. Hall(4), Daniel F. Heitjan(4), Charles R. Geard(3), Venkatraman Seshan(3), Cheng‐Shie Wuu(3), Tian Liu(3), Bozena Malyszko(3), Kathleen O’Toole(3), S. B. Horwitz(2), Encouse B. Golden(2), Silvia C. Formenti(2), James J. Manfredi(2), Jerome Parness(2)